Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 15-Nov-24
Select bar for recommendation details.
Recommendations | 15-Nov-24 | |
---|---|---|
Buy | 6 | |
Outperform | 16 | |
Hold | 9 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 28 analysts offering 12 month price targets for AbbVie Inc have a median target of 209.00, with a high estimate of 240.00 and a low estimate of 165.00. The median estimate represents a 24.58% increase from the last price of 167.76.
High | 43.1% | 240.00 |
Med | 24.6% | 209.00 |
Low | -1.6% | 165.00 |
Dividends in USD
Div growth (TTM) | 4.96% |
---|
More ▼
Earnings history & estimates in USD
The next earnings announcement is expected on Jan 31, 2025.
Average growth rate | +1.32% |
Average growth rate | +6.81% |
More ▼
Revenue history & estimates in USD
Average growth rate | +1.56% |
Average growth rate | +14.31% |
More ▼